首页> 外国专利> MONOCLONAL ANTIBODY AGAINST AURORA-A, ITS MANUFACTURING PROCESSES AND ITS USE IN THE DIAGNOSIS AND TREATMENT OF CANCER

MONOCLONAL ANTIBODY AGAINST AURORA-A, ITS MANUFACTURING PROCESSES AND ITS USE IN THE DIAGNOSIS AND TREATMENT OF CANCER

机译:抗Aurora-A的单克隆抗体,其制备方法及其在癌症诊断和治疗中的应用

摘要

Monoclonal antibody (MAb) that recognizes specifically the human or murine aurora-A kinase (I) binds to membranes that contain (I), can detect and optionally purify (I) by immunoprecipitation, stains biological tissues where (I) is secreted and does not inhibit the enzymatic activity of (I), is new. Independent claims are also included for the following: (1) in vitro diagnosis and prognosis of solid tumors (of breast, stomach or colon-rectum) in humans or animals, using MAb to detect, and optionally quantify, (I) in biological samples; (2) kit for performing method (1), comprising MAb and optionally a marker of cell proliferation, preferably a marker of PCNA, especially an antibody; (3) screening for inhibitors of (I); and (4) preparing MAb.
机译:特异性识别人或鼠源极光A激酶(I)与包含(I)的膜结合的单克隆抗体(MAb),可以通过免疫沉淀检测和可选地纯化(I),对分泌(I)的生物组织染色并能不抑制(I)的酶活性,是新的。还包括以下方面的独立权利要求:(1)使用MAb检测并可选地量化(I)生物样品中人或动物实体瘤(乳腺,胃或结肠直肠结肠癌)的体外诊断和预后; (2)用于执行方法(1)的试剂盒,其包含MAb和任选的细胞增殖标志物,优选PCNA标志物,尤其是抗体; (3)筛选(I)的抑制剂; (4)制备单克隆抗体。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号